Canna~Fangled Abstracts Multiple Sclerosis: Vaporized Cannabinoid Therapy Evaluation J Clin Med. 2025 Mar 20;14(6):2121. doi: 10.3390/jcm14062121. Evaluating Vaporized Cannabinoid Therapy in Multiple Sclerosis:…Freedom WaresMarch 20, 2025
Canna~Fangled Abstracts Disease-Modifying Symptomatic Treatment (DMST) Potential of Cannabinoids in Patients with Multiple Sclerosis Curr Neuropharmacol. 2024 Sep 13. doi: 10.2174/011570159X329058240820070701. Online ahead of print. Antonio Bruno 1, Pietro Annovazzi 2, Marinella Clerico 3, Eleonora…Freedom WaresSeptember 13, 2024
Canna~Fangled Abstracts The role of the peripheral cannabinoid system in the pathogenesis of detrusor overactivity evoked by increased intravesical osmolarity in rats. 2015 Aug;93(8):721-6. doi: 10.1139/cjpp-2015-0091. Epub 2015 Apr 13. Juszczak K1,2, Maciukiewicz P1. Author information Abstract The cannabinoid receptors…Freedom WaresAugust 6, 2015
Canna~Fangled Abstracts Diuretic effects of cannabinoid agonists in mice. Diuretic effects of cannabinoid agonists in mice. Chopda GR, Vemuri VK, Sharma R, Thakur GA, Makriyannis A, Paronis CA. Source Department of…Freedom WaresOctober 9, 2013
Canna~Fangled Abstracts Cannabinoid receptors 1 and 2 are associated with bladder dysfunction in an experimental diabetic rat model. Cannabinoid receptors 1 and 2 are associated with bladder dysfunction in an experimental diabetic rat model.…Freedom WaresJune 26, 2013
Canna~Fangled Abstracts Cannabinoids: potential targets for bladder dysfunction. 2011;(202):425-51. doi: 10.1007/978-3-642-16499-6_20. Cannabinoids: potential targets for bladder dysfunction. Ruggieri MR Sr. Author information Abstract…Freedom WaresApril 20, 2011